Lv5
1180 积分 2024-05-20 加入
Development and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers
6小时前
待确认
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
1个月前
已完结
Differential impact of IDH1/2 mutations on outcome in adult acute myeloid leukemia patients
1个月前
已关闭
[Research Progress of IDH Mutation in Acute Myeloid Leukemia--Review]
2个月前
已关闭
Normalized QRS Duration by LV Dimension: Eliminating Sex-Specific Differences and Predicting Cardiac Resynchronization Therapy Outcomes
2个月前
已完结
Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex‐Stratified Analysis of the GIMEMA AML1310 Trial
3个月前
已完结
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression Models
4个月前
已完结
USP7 inhibitor P5091 enhances the antitumor efficacy of vemurafenib in BRAFV600E-mutant thyroid cancer via ferroptosis
5个月前
已完结
Current Frontline Treatment of Diffuse Large B-Cell Lymphoma
5个月前
已完结
Clinical development of IDH1 inhibitors for cancer therapy
9个月前
已完结
皖公网安备34019202002308
